Description
Lanluma V 1x15ml – Injectable PLLA Biostimulator
Lanluma V 1x15ml is a professional injectable poly-L-lactic acid (PLLA) biostimulatory treatment designed to restore volume, improve skin firmness, and stimulate long-term collagen production. Supplied as a sterile powder vial containing 210 mg PLLA, Lanluma V is reconstituted prior to injection and is intended for deep dermal and subcutaneous use in face and body treatments.
Unlike hyaluronic acid fillers that provide immediate volume through gel implantation, Lanluma V works by stimulating the body’s natural collagen synthesis, delivering progressive, natural-looking volume restoration and skin quality improvement over time.
What Lanluma V Is Similar To
Lanluma V belongs to the category of collagen-stimulating injectables and is clinically comparable to other PLLA-based biostimulators such as Sculptra®. These products focus on bioremodeling and volumization through neocollagenesis, rather than direct filling.
This comparison is provided for professional reference only and does not imply interchangeability.
Treatment Areas / Indications
According to manufacturer documentation, Lanluma V 1x15ml is indicated for:
Treatment areas:
-
Face (cheeks, temples, jawline)
-
Mid-face volume loss
-
Body contouring (buttocks, hips, thighs)
-
Skin laxity and collagen depletion
-
Volume restoration following aging or weight loss
→ Lanluma V is particularly suited for patients seeking long-lasting volume correction and structural support with gradual, natural results.
Usage / Administration (IFU-Only)
-
Injection depth: Deep dermal to subcutaneous plane
-
Product preparation: Requires reconstitution with sterile water for injection (volume as per IFU)
-
Injection technique: Cannula or needle using fanning or cross-hatching techniques
-
Treatment protocol: Typically 1–3 sessions spaced 4–6 weeks apart
-
Longevity: Results develop gradually over weeks and can last up to 24 months
-
Professional-use disclaimer: For use only by trained and qualified medical or aesthetic practitioners
If any parameter is not explicitly stated in the official IFU, it is considered not provided by the manufacturer.
Ingredient List (Lanluma V Ingredients)
-
Poly-L-lactic acid (PLLA): 210 mg
-
Sodium carboxymethylcellulose
-
Mannitol
Lanluma V does not contain lidocaine. Reconstitution and dilution must follow official manufacturer instructions.
Presentation & Longevity
-
Presentation: 1 × 15 ml vial (powder form)
-
Reconstitution: Required prior to use
-
Shelf life: Refer to packaging for expiry date
-
Treatment longevity: Progressive collagen stimulation with results lasting up to 18–24 months, depending on patient factors and protocol
Safety Notes / Contraindications
-
Contraindicated in patients with hypersensitivity to PLLA or any excipients
-
Do not inject into areas with active infection or inflammation
-
Not suitable for intravascular injection
-
Strict aseptic technique required
-
Practitioner must have advanced anatomical knowledge and biostimulator training
Regulatory Status
CE-marked medical device in applicable regions. Regulatory classification, approved indications, and usage protocols may vary by country. Practitioners should always consult the official IFU and comply with local regulations.
FAQ
1. What is Lanluma V used for?
Lanluma V is used for collagen stimulation, volume restoration, and skin firmness improvement in both facial and body treatments.
2. How does Lanluma V work?
Lanluma V contains PLLA, which stimulates fibroblasts to produce new collagen over time. This leads to gradual volumization and improved skin structure rather than immediate filling.
3. Is Lanluma V the same as a dermal filler?
No. Lanluma V is a biostimulator, not a traditional filler. It works progressively by inducing collagen production rather than instantly adding volume.
4. How long do Lanluma V results last?
Results typically last 18 to 24 months, depending on patient metabolism, treatment area, and number of sessions.
5. What training is required to use Lanluma V?
Advanced injector training is strongly recommended. Proper education in PLLA reconstitution, injection technique, and anatomy is essential for safe and effective outcomes.
